title: Regional brain responses to serotonin in major depressive disorder.
abstract: BACKGROUND
  Positron Emission Tomography (PET) studies have reported altered resting regional brain glucose metabolism in mood disorders. This study examines the relationship of such changes to serotonin system abnormalities associated with depression.
  
  
  METHODS
  Thirteen male medication free subjects who were inpatients with a DSM-IIIR major depressive disorder and seven healthy male subjects underwent an [18F]-fluorodeoxyglucose (18FDG) PET scan on consecutive days. Three hours prior to 18FDG subjects received single blind placebo or fenfluramine. Comparisons of voxel level regional glucose metabolic rate responses (rCMRglu) between groups in the two states were performed with SPM99.
  
  
  RESULTS
  Unlike healthy male subjects who have significant increases in rCMRglu in prefrontal and parietal cortical regions after receiving fenfluramine, depressed male subjects have no significant increases in rCMRglu.
  
  
  CONCLUSIONS
  Blunted increases in rCMRglu in response to fenfluramine in prefrontal and parietal cortex are consistent with our previous pilot study and the indoleamine hypothesis of depression. Differences in specific brain regions affected between this study and previous studies may be attributable to gender differences.
authors.affiliation: Department of Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA.
authors.forename: Amy D
authors.initials: AD
authors.lastname: Anderson
authors.forename: Maria A
authors.initials: MA
authors.lastname: Oquendo
authors.forename: Ramin V
authors.initials: RV
authors.lastname: Parsey
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Milak
authors.forename: Carl
authors.initials: C
authors.lastname: Campbell
authors.forename: J John
authors.initials: JJ
authors.lastname: Mann
mesh_terms: D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003865:Major Depressive Disorder / Q000378:metabolism*; D005277:Fenfluramine / Q000008:administration & dosage / Q000494:pharmacology; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D010296:Parietal Lobe / Q000187:drug effects / Q000378:metabolism; D049268:Positron-Emission Tomography; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D019275:Radiopharmaceuticals; D012701:Serotonin / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D005277:Fenfluramine; D019788:Fluorodeoxyglucose F18; D005947:Glucose; D019275:Radiopharmaceuticals; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors